Iterum TherapeuticsITRMF
13F holders, Q4 2024 (December 31)4holders +1
1new positions
0sold out
$1.77avg. 13F price*
At the end of Q4 2024, 4 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Creative Financial Designs Inc. ($106K), Cypress Capital Management LLC (WY) ($117) and Blue Bell Private Wealth Management, LLC ($117).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L101
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $106K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 59,900 shares bought, net +59,900 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Creative Financial Designs Inc. | 0.01% | New | 59,900 | $106K |
| Cypress Capital Management LLC (WY) | 0.00% | No change | 66 | $117 |
| Blue Bell Private Wealth Management, LLC | 0.00% | No change | 66 | $117 |
| Avior Wealth Management, LLC | 0.00% | No change | 13 | $23 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.